Home › Polycythemia Vera › Pennsylvania
Polycythemia Vera clinical trials in Pennsylvania
5 studies for Polycythemia Vera are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
- UPMC Hillman Cancer Center ( Site 6004), Pittsburgh
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT06351631INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
- Fox Chase Cancer Center, Philadelphia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07429266A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Trials Office, Philadelphia
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07469891Two Step Haplo With Radiation Conditioning
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadephia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 30, 2025 · NCT05031897Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition
- Fox Chase Cancer Center - Philadelphia, Philadelphia
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 3, 2024 · NCT06218628From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.